Get more replies from employers
Send a job-specific resume in minutes.
Eisai US is seeking a Director of Translational Science (Neurology) to drive translational strategies across neurology programs from discovery to early clinical development. The role focuses on linking disease biology, biomarkers, and outcomes to enable data-driven decisions, complementing Alzheimer’s focus with non-Alzheimer’s neurodegenerative expertise.
The candidate will lead biomarker strategy, data interpretation, and cross-functional collaboration, mentored by senior leadership and
At Eisai, satisfying unmet medical needs and increasing the benefits healthcare provides to patients, their families, and caregivers is Eisai’s human health care (hhc) mission. We’re a growing pharmaceutical company that is breaking through in neurology and oncology, with a strong emphasis on research and development. Our history includes the development of many innovative medicines, notably the discovery of the world's most widely-used treatment for Alzheimer’s disease. As we continue to expand, we are seeking highly-motivated individuals who want to work in a fast-paced environment and make a difference. If this is your profile, we want to hear from you.
Director, Translational Science (Neurology) Position Summary The Director of Translational Science is a scientifically driven leader who contributes to and drives the execution of integrated translational strategies across neurology programs spanning discovery through early clinical development. This role focuses on enabling data-driven decision-making by linking disease biology, biomarkers, and clinical outcomes. This position is designed to complement existing expertise in Alzheimer’s disease by bringing deep knowledge in non-Alzheimer’s neurodegenerative disorders, including Parkinson’s disease, Lewy body dementia, primary tauopathies, and sleep-related neurobiology. The successful candidate will combine strong scientific insight with hands-on engagement in biomarker strategy, data interpretation, and cross-functional collaboration.
You will join a collaborative and innovative translational science team focused on advancing the next generation of therapies for neurodegenerative diseases. This role offers the opportunity to shape translational strategy, deepen understanding of complex disease biology, and contribute meaningfully to improving patient outcomes.
The annual base salary range for the Director, Translational Science (Neurology) is from :$204,300-$268,200
Under current guidelines, this position is eligible to participate in : Eisai Inc. Annual Incentive Plan & Eisai Inc. Long Term Incentive Plan. Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills. Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit https://careers.eisai.com/us/en/compensation-and-benefits. Certain other benefits may be available for this position
Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status. Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.
Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Right To Work E-Verify Participation At Eisai Inc., human health care (hhc) is our goal.
As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina.